PAX3 is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.

作者: Liang Xia , Qingfeng Huang , Dekang Nie , Jinlong Shi , Mingjie Gong

DOI: 10.1016/J.BRAINRES.2013.05.021

关键词: Molecular biologyCancer researchApoptosisU87Downregulation and upregulationBiologyCell growthGliomaTransfectionAnnexinCell culture

摘要: Paired box 3 (PAX3) is overexpressed in glioma tissues compared to normal brain tissues, however, the pathogenic role of PAX3 human cells remains be elucidated. In this study, we selected cell lines U251, U87, SHG-44, and astrocytes, 1800, which have differential expression depending upon person. SiRNA targeting overexpression vectors were transfected into U87 SHG-44 lines, proliferation, invasion, apoptosis, differentiation examined by CCK-8 assays, transwell chamber tunnel staining, Annexin V/PI analysis, Western blotting, respectively. addition, used subcutaneous tumor models study effect on growth vivo. We found that was upregulated three lines. knockdown inhibited proliferation induced apoptosis U87MG glioblastoma line, whereas upregulation promoted increased invasion line. Moreover, together with chemotherapeutic treatment could increase susceptibility drug. nude mice using U-87MG inhibition suppressed tumorigenicity, formation These results indicate essential for gliomagenesis; thus, or its downstream targets may lead novel therapies disease.

参考文章(26)
Ricardo J. Komotar, Marc L. Otten, Gaetan Moise, E. Sander Connolly, Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma—A Critical Review: Clinical Medicine: Oncology. ,vol. 2, pp. 421- 422 ,(2008) , 10.4137/CMO.S390
Emanuela Frascella, Luisa Toffolatti, Angelo Rosolen, Normal and rearranged PAX3 expression in human rhabdomyosarcoma. Cancer Genetics and Cytogenetics. ,vol. 102, pp. 104- 109 ,(1998) , 10.1016/S0165-4608(97)00352-X
Riccardo Soffietti, Barbara Leoncini, Roberta Rudà, New developments in the treatment of malignant gliomas. Expert Review of Neurotherapeutics. ,vol. 7, pp. 1313- 1326 ,(2007) , 10.1586/14737175.7.10.1313
Theodor W. Schulte, Jeffrey A. Toretsky, Elisabeth Ress, Lee Helman, Leonard M. Neckers, Expression of PAX3 in Ewing's sarcoma family of tumors. Biochemical and Molecular Medicine. ,vol. 60, pp. 121- 126 ,(1997) , 10.1006/BMME.1997.2567
Atsushi Watanabe, Kazuhisa Takeda, Barbara Ploplis, Masayoshi Tachibana, Epistatic Relationship Between Waardenburg Syndrome Genes MITF and PAX3 Nature Genetics. ,vol. 18, pp. 283- 286 ,(1998) , 10.1038/NG0398-283
Jian Chen, Liang Xia, Xiujie Wu, Liqin Xu, Dekang Nie, Jinlong Shi, Xide Xu, Lanchun Ni, Shaoqing Ju, Xinhua Wu, Hui Zhu, Wei Shi, None, Clinical Significance and Prognostic Value of PAX3 Expression in Human Glioma Journal of Molecular Neuroscience. ,vol. 47, pp. 52- 58 ,(2012) , 10.1007/S12031-011-9677-1
Aleksandra Muratovska, Chaoming Zhou, Shuji He, Paul Goodyer, Michael R Eccles, Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival Oncogene. ,vol. 22, pp. 7989- 7997 ,(2003) , 10.1038/SJ.ONC.1206766
Qiuyu Wang, Wen-Hui Fang, Jerzy Krupinski, Shant Kumar, Mark Slevin, Patricia Kumar, Pax genes in embryogenesis and oncogenesis. Journal of Cellular and Molecular Medicine. ,vol. 12, pp. 2281- 2294 ,(2008) , 10.1111/J.1582-4934.2008.00427.X
Rebecca S Plummer, Christopher R Shea, Maria Nelson, Sara K Powell, Diane M Freeman, Colleen P Dan, Deborah Lang, PAX3 expression in primary melanomas and nevi. Modern Pathology. ,vol. 21, pp. 525- 530 ,(2008) , 10.1038/MODPATHOL.3801019
Naoki Niikura, Takayuki Iwamoto, Shinobu Masuda, Nobue Kumaki, Tang Xiaoyan, Masatoshi Shirane, Kazushige Mori, Banri Tsuda, Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda, None, Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer Cancer Science. ,vol. 103, pp. 1508- 1512 ,(2012) , 10.1111/J.1349-7006.2012.02319.X